# Single-Cell Transcriptomic Profile Associated with Sub-Subtype A6 and CRF63-02A6 HIV-1 Strain Infection

**Authors:** Kirill Elfimov, Anna Khozyainova, Ludmila Gotfrid, Dmitriy Baboshko, Dmitry Kapustin, Polina Achigecheva, Vasiliy Ekushov, Maksim Halikov, Mariya Gashnikova, Tatyana Bauer, Tatyana Tregubchak, Andrey Murzin, Arina Kiryakina, Aleksei Totmenin, Aleksandr Agaphonov, Natalya Gashnikova

PMC · DOI: 10.3390/v18020204 · Viruses · 2026-02-04

## TL;DR

This study uses single-cell RNA sequencing to analyze immune responses in early HIV-1 infection caused by sub-subtypes A6 and CRF63-02A6, which are common in Russia and the FSU.

## Contribution

The paper provides the first single-cell transcriptional atlas of immune responses to HIV-1 sub-subtypes A6 and CRF63-02A6 during acute infection.

## Key findings

- Early HIV-1 infection causes significant reorganization of immune cell transcriptional programs.
- Pro-inflammatory pathways and metabolic adaptations are activated in key immune cells.
- Dysregulation of TGF-β and mTOR signaling is observed, along with altered intercellular communication.

## Abstract

We present the single-cell transcriptomic analysis of peripheral blood mononuclear cells (PBMC) from individuals during acute HIV-1 infection caused by viral strains circulating in Russia and the Former Soviet Union (FSU) countries. Using 10x Genomics single-cell RNA sequencing (scRNA-seq) on the Illumina NextSeq 550 platform, we have analyzed scRNA-seq data from three treatment-naive patients (viral load > 1 × 106 copies/mL, estimated infection duration ≤ 4 weeks) and three healthy donors. Data integration (Seurat, Harmony), automated cell-type annotation (CellTypist), and GeneOntology (GO) enrichment analysis for highly expressed and low-expressed genes revealed a profound reorganization of transcriptional programs across key immune populations, including memory CD4+ and CD8+ T cells, non-classical monocytes and natural killer cells (NK-cells). We observed signatures of hyperactivation of pro-inflammatory pathways (NF-kB, TNF, and type I/II interferon signaling), upregulation of genes associated with cellular migration (CXCR4, CCR7) and metabolic adaptation (oxidative phosphorylation components), alongside a mixed pro- and anti-apoptotic expression profile. Notably, our data pointed to a pronounced dysregulation of the TGF-β and mTOR signaling cascades, disrupted intercellular communication networks—particularly between cytotoxic cells and their regulators—altered expression of genes implicated in disease progression (OLR1, SERPINB2, COPS9) and viral persistence control (NEAT1, NAF1). This work provides an initial single-cell transcriptional atlas characterizing early immune responses to HIV-1 sub-subtypes A6 and CRF63_02A6, the predominant drivers of the HIV epidemic across the FSU region.

## Linked entities

- **Genes:** CXCR4 (C-X-C motif chemokine receptor 4) [NCBI Gene 7852], CCR7 (C-C motif chemokine receptor 7) [NCBI Gene 1236], OLR1 (oxidized low density lipoprotein receptor 1) [NCBI Gene 4973], SERPINB2 (serpin family B member 2) [NCBI Gene 5055], COPS9 (COP9 signalosome subunit 9) [NCBI Gene 150678], NEAT1 (nuclear paraspeckle assembly transcript 1) [NCBI Gene 283131], NAF1 (nuclear assembly factor 1 ribonucleoprotein) [NCBI Gene 92345]

## Full-text entities

- **Genes:** VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, NR4A3 (nuclear receptor subfamily 4 group A member 3) [NCBI Gene 8013] {aka CHN, CSMF, MINOR, NOR1}, IRAK2 (interleukin 1 receptor associated kinase 2) [NCBI Gene 3656] {aka IRAK-2}, CCL5 (C-C motif chemokine ligand 5) [NCBI Gene 6352] {aka D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228}, IL21R (interleukin 21 receptor) [NCBI Gene 50615] {aka CD360, IMD56, NILR}, HLA-B (major histocompatibility complex, class I, B) [NCBI Gene 3106] {aka AS, B-4901, HLAB}, IL16 (interleukin 16) [NCBI Gene 3603] {aka LCF, NIL16, PRIL16, prIL-16}, SMN1 (survival of motor neuron 1, telomeric) [NCBI Gene 6606] {aka BCD541, GEMIN1, SMA, SMA1, SMA2, SMA3}, DUSP4 (dual specificity phosphatase 4) [NCBI Gene 1846] {aka HVH2, MKP-2, MKP2, TYP}, MAP3K1 (mitogen-activated protein kinase kinase kinase 1) [NCBI Gene 4214] {aka MAPKKK1, MEKK, MEKK 1, MEKK1, SRXY6}, FOSL2 (FOS like 2, AP-1 transcription factor subunit) [NCBI Gene 2355] {aka ACED, FRA2}, COPS9 (COP9 signalosome subunit 9) [NCBI Gene 150678] {aka CSNAP, MYEOV2}, CCL3 (C-C motif chemokine ligand 3) [NCBI Gene 6348] {aka G0S19-1, LD78, LD78ALPHA, MIP-1-alpha, MIP1A, SCI}, COX7B (cytochrome c oxidase subunit 7B) [NCBI Gene 1349] {aka APLCC, LSDMCA2}, RAP1GAP2 (RAP1 GTPase activating protein 2) [NCBI Gene 23108] {aka GARNL4, RAP1GA3}, PCBP3 (poly(rC) binding protein 3) [NCBI Gene 54039] {aka ALPHA-CP3, PCBP3-OT1, PCBP3OT}, JARID2 (jumonji and AT-rich interaction domain containing 2) [NCBI Gene 3720] {aka DIDDF, JMJ}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, FLT3 (fms related receptor tyrosine kinase 3) [NCBI Gene 2322] {aka CD135, FLK-2, FLK2, STK1}, NT5C (5', 3'-nucleotidase, cytosolic) [NCBI Gene 30833] {aka DNT, DNT1, HEL74, P5N2, PN-I, PN-II}, RPL31 (ribosomal protein L31) [NCBI Gene 6160] {aka L31, eL31}, RPL35A (ribosomal protein L35a) [NCBI Gene 6165] {aka DBA5, L35A, eL33}, FCHSD2 (FCH and double SH3 domains 2) [NCBI Gene 9873] {aka NWK, NWK1, SH3MD3}, ARRDC2 (arrestin domain containing 2) [NCBI Gene 27106] {aka CLONE24945, PP2703}, SERPINB2 (serpin family B member 2) [NCBI Gene 5055] {aka HsT1201, PAI, PAI-2, PAI2, PLANH2}, PDE7A (phosphodiesterase 7A) [NCBI Gene 5150] {aka HCP1, PDE7}, LGALS9 (galectin 9) [NCBI Gene 3965] {aka HUAT, LGALS9A}, SC5D (sterol-C5-desaturase) [NCBI Gene 6309] {aka ERG3, S5DES, SC5DL}, ANXA1 (annexin A1) [NCBI Gene 301] {aka ANX1, LPC1}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, A2M (alpha-2-macroglobulin) [NCBI Gene 2] {aka A2MD, CPAMD5, FWP007, S863-7}, TXNIP (thioredoxin interacting protein) [NCBI Gene 10628] {aka ARRDC6, EST01027, HHCPA78, THIF, VDUP1}, FAM177A1 (family with sequence similarity 177 member A1) [NCBI Gene 283635] {aka C14orf24, NEDWMG}, MAP2K6 (mitogen-activated protein kinase kinase 6) [NCBI Gene 5608] {aka CRCMSL, MAPKK6, MEK6, MKK6, PRKMK6, SAPKK-3}, SKIL (SKI like proto-oncogene) [NCBI Gene 6498] {aka SNO, SnoA, SnoI, SnoN}, P2RY8 (P2Y receptor family member 8) [NCBI Gene 286530] {aka P2Y8}, OLR1 (oxidized low density lipoprotein receptor 1) [NCBI Gene 4973] {aka CLEC8A, LOX1, LOXIN, SCARE1, SLOX1}, AUTS2 (activator of transcription and developmental regulator AUTS2) [NCBI Gene 26053] {aka FBRSL2, MRD26}, GRN (granulin precursor) [NCBI Gene 2896] {aka CLN11, FTD2, GEP, GP88, PCDGF, PEPI}, BCR (BCR activator of RhoGEF and GTPase) [NCBI Gene 613] {aka ALL, BCR1, CML, D22S11, D22S662, PHL}, PLCB1 (phospholipase C beta 1) [NCBI Gene 23236] {aka DEE12, EIEE12, PI-PLC, PLC-154, PLC-I, PLC-beta-1}, OTULIN (OTU deubiquitinase with linear linkage specificity) [NCBI Gene 90268] {aka AIPDS, AIPDSA, FAM105B, GUM, IMD107}, Nef [NCBI Gene 156110], CXCR3 (C-X-C motif chemokine receptor 3) [NCBI Gene 2833] {aka CD182, CD183, CKR-L2, CMKAR3, GPR9, IP10-R}, ST6GAL1 (ST6 beta-galactoside alpha-2,6-sialyltransferase 1) [NCBI Gene 6480] {aka CDw75, SIAT1, ST6GalI, ST6N}, NR4A1 (nuclear receptor subfamily 4 group A member 1) [NCBI Gene 3164] {aka GFRP1, HMR, N10, NAK-1, NGFIB, NP10}, DSE (dermatan sulfate epimerase) [NCBI Gene 29940] {aka DS-epi1, DSEP, DSEPI, EDSMC2, SART-2, SART2}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, TUBA4A (tubulin alpha 4a) [NCBI Gene 7277] {aka ALS22, CMYO26, FTDALS9, H2-ALPHA, OZEMA23, SPAX11}, BICDL1 (BICD family like cargo adaptor 1) [NCBI Gene 92558] {aka BICDR-1, BICDR1, CCDC64, CCDC64A, H_267D11.1}, ARHGEF2 (Rho/Rac guanine nucleotide exchange factor 2) [NCBI Gene 9181] {aka GEF, GEF-H1, GEFH1, LFP40, Lfc, NEDMHM}, STX8 (syntaxin 8) [NCBI Gene 9482] {aka CARB}, GZMH (granzyme H) [NCBI Gene 2999] {aka CCP-X, CGL-2, CSP-C, CTLA1, CTSGL2}, RPL24 (ribosomal protein L24) [NCBI Gene 6152] {aka HEL-S-310, L24, eL24}, ARHGAP26 (Rho GTPase activating protein 26) [NCBI Gene 23092] {aka GRAF, GRAF1, OPHN1L, OPHN1L1}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, TRERF1 (transcriptional regulating factor 1) [NCBI Gene 55809] {aka BCAR2, HSA277276, RAPA, TREP132, TReP-132, dJ139D8.5}, SOCS1 (suppressor of cytokine signaling 1) [NCBI Gene 8651] {aka AISIMD, CIS1, CISH1, JAB, SOCS-1, SSI-1}, CD38 (CD38 molecule) [NCBI Gene 952] {aka ADPRC 1, ADPRC1, cADPR1}, HLA-C (major histocompatibility complex, class I, C) [NCBI Gene 3107] {aka D6S204, HLA-JY3, HLAC, HLC-C, MHC, PSORS1}
- **Diseases:** Kaposi's sarcoma (MESH:D012514), hypoxia (MESH:D000860), acute (MESH:D000208), viremia (MESH:D014766), CRFs (MESH:C535296), opportunistic infections (MESH:D009894), inflammation (MESH:D007249), neurodegenerative diseases (MESH:D019636), injury to (MESH:D014947), HIV Infection (MESH:D015658), immune dysregulation (OMIM:614878), nephropathy (MESH:D007674), cytotoxic (MESH:D064420), A6/CRF63_02A6 infection (MESH:C537092), Infection (MESH:D007239), COVID-19 (MESH:D000086382), immune deficiency (MESH:D007154), viral infections (MESH:D014777), SCT (MESH:C535780), chronic infection (MESH:D000088562)
- **Chemicals:** cholesterol (MESH:D002784), ethanol (MESH:D000431), water (MESH:D014867), ethidium bromide (MESH:D004996), nitrogen (MESH:D009584), Trypan Blue (MESH:D014343), DMSO (MESH:D004121), calcium (MESH:D002118), sphingolipid (MESH:D013107), PBS (MESH:D007854), lipid (MESH:D008055), agarose (MESH:D012685), ATP (MESH:D000255), purine nucleotide (MESH:D011685), 100ML (-)
- **Species:** Human immunodeficiency virus 1 (no rank) [taxon 11676], Homo sapiens (human, species) [taxon 9606], Human immunodeficiency virus (species) [taxon 12721]
- **Cell lines:** DYE-01-4 — Mus musculus (Mouse), Induced pluripotent stem cell (CVCL_A4VY), PN 120270 — Homo sapiens (Human), Primitive neuroectodermal tumor, Cancer cell line (CVCL_VK47)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12944885/full.md

## Figures

13 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12944885/full.md

## References

61 references — full list in the complete paper: https://tomesphere.com/paper/PMC12944885/full.md

---
Source: https://tomesphere.com/paper/PMC12944885